Oncolytics Biotech, Inc. (ONCY)
1.00
0.00 (0.00%)
USD |
NASDAQ |
Dec 12, 10:33
Oncolytics Biotech Free Cash Flow: -18.79M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Aurinia Pharmaceuticals, Inc. | 120.39M |
| Edesa Biotech, Inc. | -6.650M |
| Lexaria Bioscience Corp. | -10.55M |
| Xenon Pharmaceuticals, Inc. | -253.05M |
| ProMIS Neurosciences, Inc. | -27.36M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.870M |
| Cash from Investing (Quarterly) | -0.0051M |
| Cash from Financing (Quarterly) | 3.043M |
| Free Cash Flow Per Share (Quarterly) | -0.0481 |
| Free Cash Flow to Equity (Quarterly) | -4.825M |
| Free Cash Flow to Firm (Quarterly) | -4.875M |
| Free Cash Flow Yield | -21.19% |